GCITX | VTSNX | GCITX / VTSNX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 14 years | - |
Gain YTD | 5.695 | 6.076 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.91B | 443B | 0% |
Annual Yield % from dividends | 2.62 | 3.29 | 80% |
Returns for 1 year | 8.17 | 8.83 | 92% |
Returns for 3 years | 11.97 | 1.10 | 1,084% |
Returns for 5 years | 24.73 | 14.00 | 177% |
Returns for 10 years | 72.30 | 35.72 | 202% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECEIX | 10.73 | -0.04 | -0.37% |
Lazard Emerging Markets Core Equity Inst | |||
MACEX | 12.75 | -0.07 | -0.51% |
Martin Currie Emerging Markets A | |||
GMOUX | 25.39 | -0.14 | -0.55% |
GMO International Equity I | |||
FRVLX | 62.10 | -1.04 | -1.65% |
Franklin Small Cap Value A | |||
LMCQX | 33.92 | -3.37 | -9.04% |
Lord Abbett Mid Cap Stock R2 |